Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LPCN compared with ZNTL: revenue, margins and what each company keeps, and the suppliers and customers both name
LPCN
Lipocine Inc.
Change
Mkt cap
Revenue
Revenue
ZNTL
Zentalis Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LPCN
Lipocine Inc.
vs
ZNTL
Zentalis Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LPCN, solid
ZNTL, dashed
LPCN
Lipocine Inc.
Change
1.58
▲
+3.56%
· post 1.55
Mkt cap
$17.4M
Revenue
$2M
Q3 FY26
Revenue
$2M
FY25
ZNTL
Zentalis Pharmaceuticals, Inc.
Change
1.73
▲
+1.17%
· post 1.73
Closed
Nov 6 '26
Mkt cap
$123.3M
Revenue
$27M
Q4 FY24
Revenue
—
vs
Compare
Closed
Nov 6 '26
LPCN
Lipocine Inc.
vs
ZNTL
Zentalis Pharmaceuticals, Inc.
1.58
▲
+3.56%
post 1.55
Price
1.73
▲
+1.17%
post 1.73
$17.4M
Mkt cap
$123.3M
Q3 FY26
$2M
Revenue
$27M
Q4 FY24
FY25
$2M
Revenue
—
Change
Change
LPCN
1.58
▲
+3.56%
vs
ZNTL
1.73
▲
+1.17%
Closed
Nov 6 '26